.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research into the Pathogen Hypothesis of Alzheimer's examines how infectious agents might contribute to dementia. While the 2024 Lancet Commission identified 14 modifiable risk factors, it omitted pathogens due to causality debates. However, new quantitative analyses suggest that viruses and bacteria play a significant role in neuroinflammation and amyloidogenesis.
Researchers utilized nationwide cohort studies to apply a Population Attributable Fraction (PAF) model. This study specifically evaluated pathogens such as Herpes Simplex Virus Type 1 (HSV-1), Porphyromonas gingivalis, and Chlamydia pneumoniae. Findings suggest that infectious agents could account for 19% to 31% of cases in single-pathogen models. In joint models of sporadic cases, this burden expands to a range of 31% to 52%.
The study also highlights a synergistic interaction with the APOE ε4 allele. Furthermore, investigators addressed failures in antimicrobial clinical trials like VALAD and GAIN. They argue that these results demonstrate a need for precision biomarker stratification rather than a refutation of the hypothesis. Consequently, integrating pathogen suppression into prevention protocols may be vital for future care.
Key pathogens include Herpes Simplex Virus Type 1 (HSV-1), Porphyromonas gingivalis (associated with gum disease), and Chlamydia pneumoniae.
Experts suggest these trials likely failed because they lacked precision biomarker stratification to identify patients most likely to benefit from treatment.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Bender O et al. Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease. J Alzheimers Dis. 2026 May 11. doi: 10.1177/13872877261447530. PMID: 42115784.
Livingston G et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Commission. Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0.
Itzhaki RF et al. Microbes and Alzheimer's Disease. J Alzheimers Dis. 2016;51(4):979-84. doi: 10.3233/JAD-160152.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New quantitative models suggest infectious pathogens contribute significantly to Alzheimer's disease burden, potentially accounting for up to 52% of cases....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
